PFAS exposure is most strongly linked to kidney and testicular cancer, with growing evidence connecting these chemicals to breast, prostate, and liver cancers as well. In 2023, the International Agency for Research on Cancer (IARC) classified PFOA, one of the most common PFAS compounds, as a Group 1 carcinogen, the highest designation, meaning there is sufficient evidence it causes cancer in humans.
Kidney Cancer Has the Strongest Statistical Link
Kidney cancer is the most extensively studied cancer in relation to PFAS, with data from 11 studies showing an 18% increased risk among people exposed to these chemicals overall. At high exposure levels, the picture gets much worse. People with the highest concentrations of PFAS in their blood face roughly 74% greater risk of kidney cancer compared to those with minimal exposure. Some individual studies found the risk even higher: workers and community members near a PFOA-contaminated water supply in West Virginia showed more than double the expected kidney cancer rates.
The dose matters significantly. Studies that separated participants into low, medium, and high exposure groups found a clear upward trend, with cancer risk climbing as PFAS blood levels increased. This kind of dose-response pattern strengthens the case that PFAS is actually causing the cancer rather than just appearing alongside it by coincidence.
Testicular Cancer Shows a Strong Pattern
Testicular cancer has some of the most compelling evidence of any PFAS-linked cancer, even though the total number of cases studied is smaller. In a large cohort study of communities exposed to PFOA through contaminated drinking water, men in the highest exposure group had roughly three times the risk of testicular cancer compared to those in the lowest group, with a statistically significant upward trend across exposure levels. A separate case-control study found that men living in the most contaminated water district had five times the expected rate of testicular cancer.
An Italian mortality study of communities near a PFAS-contaminated site found nearly twice as many testicular cancer deaths as expected, though the small number of cases (eight deaths) makes that estimate less precise. What makes the testicular cancer evidence particularly convincing is that multiple study designs, conducted in different populations, point in the same direction. Animal studies have also found testicular tumors linked to PFOA exposure, adding biological support to what the human data shows.
Breast Cancer Evidence Is Building
A meta-analysis of eight studies found positive associations between breast cancer and two common PFAS compounds: PFOA and PFHxS. The relationship may depend on the type of breast cancer involved, with some evidence suggesting the link varies by hormone receptor status. One study found that PFOA accumulates more significantly in the blood of breast cancer patients, particularly at high serum concentrations above 71.3 micrograms per liter.
The connection between PFAS and breast cancer is biologically plausible because PFAS disrupt hormone signaling. These chemicals interfere with the receptors that regulate how the body processes estrogen and other hormones, and hormonal disruption is a well-established driver of breast cancer development.
Prostate, Liver, and Other Cancers Under Investigation
Laboratory research has shown that even low doses of PFOA can drive prostate cancer cells to grow, migrate, and invade surrounding tissue. The mechanism involves changes to how cells read their own genetic instructions, ultimately triggering a process called autophagy (a kind of cellular recycling) that fuels tumor growth. Epidemiological data from firefighters, who are heavily exposed to PFAS through firefighting foam, shows elevated rates of prostate cancer alongside kidney, bladder, and testicular cancers.
Liver cancer has a plausible connection as well. PFAS activate specialized immune cells in the liver, which then release inflammatory signals that promote cell growth. This chronic inflammation can set the stage for cancer over time. Firefighter studies have also flagged elevated rates of non-Hodgkin’s lymphoma and multiple myeloma, both cancers of the immune system, though the evidence for these is less developed than for kidney or testicular cancer.
Thyroid cancer is another area of concern. PFAS disrupt hormone balance broadly, and the thyroid is particularly sensitive to these disruptions. The evidence here is still early compared to kidney and testicular cancers, but the biological logic is sound.
How PFAS Drive Cancer Development
PFAS don’t cause cancer through a single mechanism. Instead, they appear to promote tumor growth through several overlapping pathways. The most well-documented include hormonal disruption, where PFAS interfere with receptors that control metabolism and reproductive hormones. This is particularly relevant for cancers of hormone-sensitive organs like the breast, prostate, thyroid, and liver.
PFAS also cause oxidative stress, a condition where the body produces too many reactive molecules that damage DNA. Over time, this DNA damage can accumulate and trigger the mutations that lead to cancer. On top of that, PFAS alter epigenetic patterns, essentially changing which genes are turned on or off without modifying the DNA sequence itself. Studies have found both increases and decreases in DNA methylation (one of the main epigenetic switches) in people exposed to PFAS, with the affected genes linked to cancer and reproductive disease.
Chronic inflammation and immune suppression round out the picture. PFAS weaken the immune system’s ability to detect and destroy abnormal cells, which is one of the body’s primary defenses against cancer. This immunotoxicity is well documented and may help explain why PFAS exposure is associated with such a wide range of cancer types rather than just one or two.
Who Faces the Highest Risk
Firefighters are among the most heavily exposed populations due to aqueous film-forming foam (AFFF), which contains high concentrations of PFAS and has been used for decades to suppress fuel fires. Studies consistently show firefighters have higher cancer rates than the general population, with kidney, bladder, testicular, and prostate cancers appearing at elevated rates. PFAS exposure from foam, contaminated air, and dust inside fire stations are all established sources.
Communities near industrial sites that manufactured or used PFAS also face elevated risk. The most studied example is the Mid-Ohio Valley, where a chemical plant released PFOA into drinking water for decades. Much of the strongest human cancer data comes from studies of these residents and plant workers.
For the general population, drinking water is the primary concern. The EPA now enforces a maximum contaminant level of 4.0 parts per trillion for both PFOA and PFOS individually, with a health goal of zero. These limits, finalized in 2024, are far stricter than previous guidelines, reflecting the growing evidence of harm at very low concentrations. If your water comes from a public system, your utility is required to test for PFAS and reduce levels that exceed these limits.
PFOA vs. PFOS: Different Risk Levels
Not all PFAS carry the same cancer risk. IARC classified PFOA as “carcinogenic to humans” (Group 1), placing it in the same category as asbestos and tobacco smoke. PFOS received a lower classification of “possibly carcinogenic to humans” (Group 2B), meaning the evidence is more limited. The distinction matters because PFOA has been more extensively studied in relation to cancer, and the human and animal data for PFOA is considerably stronger. Both compounds persist in the body for years, but PFOA appears to be the more potent carcinogen based on current evidence.